gallimune se + st, water-in-oil emulsion for injection
boehringer ingelheim vetmedica gmbh - inactivated salmonella enteritidis pt4; inactivated salmonella typhimurium dt 104 - emulsion for injection - . - salmonella - chickens - immunological - inactivated vaccine
nobilis rt+ibmulti+nd+eds emulsion for injection/infusion
intervet international b.v., netherlands - inactivated ibv strain 249g,inactivated ibv strain m41,inactivated trtv strain but18544,inactivated eds 76 strain bc14,inactivated ndv strain clone 30 - emulsion for injection/infusion - 5.5 log10 pfu/ml
avaxim 160 u inactivated adosorbed hepatitis a suspension for injection in pre-filled syring
sanofi pasteur s.a. 1541 avenue marcel mérieux, 69280 marcy,france - inactivated hepatitis a virus (gbm strain) - suspension for injection in pre-filled syring - inactivated hepatitis a virus (gbm strain) - viral vaccines: hepatitisvaccines
avaxim 80 u pediatric inactivated adosorbed suspension for injection in pre-filled syring
sanofi pasteur s.a. 1541 avenue marcel mérieux, 69280 marcy… - inactivated hepatitis a virus (gbm strain) __80 - suspension for injection in pre-filled syring - inactivated hepatitis a virus (gbm strain) __80 - viral vaccines: hepatitisvaccines
eupolio™ inj. (sabin inactivated polio vaccine) solution for injection
lg chem, ltd, e14 block lg science park, 70, magokjungang - inactivated poliovirus types 1, 2 and 3(sabin - solution for injection - a single human dose (0.5 ml) of sabin inactivated - poliomyelitis trivalent inactivated whole virus
pneumovac plus suspension for injection for cattle
animal health distributors limited - bovine respiratory syncytial virus, strain bio-24, inactivated; bovine parainfluenza 3 virus, strain bio-23, inactivated; mannheimia haemolytica, serotype a1 strain dsm 5283, inactivated; bovine viral diarrhoea virus, strain bio-25, inactavited - suspension for injection - . relative potency/dose - bovine parainfluenza virus + bovine respiratory syncytial virus + pasteurella
pneumovac suspension for injection for cattle
animal health distributors limited - bovine respiratory syncytial virus, strain bio-24 inactivated; bovine parainfluenza 3 virus, strain bio-23, inactivated; mannheimia haemolytica, serotype a1 strain dsm 5283, inactivated - suspension for injection - . relative potency/dose - bovine parainfluenza virus + bovine respiratory syncytial virus + pasteurella
fluzone quadrivalent northern hemisphere (influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (formaldehyde inactivate
sanofi pasteur inc. - influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (formaldehyde inactivated) (unii: wd5e5vym2e) (influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:erb9sj9vmq), influenza a virus a/darwin/9/2021 san-010 (h3n2) antigen (formaldehyde inactivated) (unii: kja387fhb2) (influenza a virus a/darwin/9/2021 san-010 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:6s4y8a8uey), influenza b virus b/phuket/3073/2013 antigen (formaldehy - influenza a virus a/michigan/45/2015 x-275 (h1n1) hemagglutinin antigen (formaldehyde inactivated) 15 ug in 0.5 ml - fluzone® quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine. fluzone quadrivalent is approved for use in persons 6 months of age and older. do not administer fluzone quadrivalent to anyone with a history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine [see description (11) ], including egg protein, or to a previous dose of any influenza vaccine. pregnancy exposure registry sanofi pasteur inc. is maintaining a prospective pregnancy exposure registry to collect data on pregnancy outcomes following vaccination with fluzone quadrivalent during pregnancy. healthcare providers are encouraged to enroll women who receive fluzone quadrivalent during pregnancy in sanofi pasteur inc.'s vaccination pregnancy registry by calling 1-800-822-2463. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general popul
dukoral suspension
valneva sweden ab - vibrio cholerae ogawa 50 classical biotype, formalin inactivated; recombinant cholera toxin b subunit; vibrio cholerae inaba 6973 el tor biotype, formalin inactivated; vibrio cholerae inaba 48 classical biotype, heat inactivated; vibrio cholerae ogawa 50 classical biotype, heat inactivated - suspension - 31250000000cells; 1mg; 31250000000cells; 31250000000cells; 31250000000cells - vibrio cholerae ogawa 50 classical biotype, formalin inactivated 31250000000cells; recombinant cholera toxin b subunit 1mg; vibrio cholerae inaba 6973 el tor biotype, formalin inactivated 31250000000cells; vibrio cholerae inaba 48 classical biotype, heat inactivated 31250000000cells; vibrio cholerae ogawa 50 classical biotype, heat inactivated 31250000000cells - vaccines
pentavac 0 %v/v powder for suspension for injection
sanofi pasteur msd ltd - purified diphtheria toxoid ph. eur., purified tetanus toxoid, adsorbed purified pertussis toxoid, adsorbed purified filamentous haemagglutinin, inactivated poliomyelitis virus ph. eur, inactivated type 1 poliovirus, inactivated type 2 poliovirus, inactivated type 3 poliovirus, haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0 %v/v - bacterial and viral vaccines, combined